Industri

Mr Vivek Asthana, Head EHS & Sustainability, Symbiotec ...

Indore Pharma Summit 2026 | 8th May 2026 | Indore Marriott Hotel The post Mr Vi...

Panel Discussion: From molecule to market faster: Rethi...

Indore Pharma Summit 2026 | 8th May 2026 | Indore Marriott Hotel The post Panel...

Prof (Dr) Neelesh Malviya, Principal, Smriti College of...

Indore Pharma Summit 2026 | 8th May 2026 | Indore Marriott Hotel The post Prof ...

Indore Rising: Central India’s next manufacturing power...

Indore Pharma Summit 2026 | 8th May 2026 | Indore Marriott Hotel The post Indor...

Mr Gajanan Patil, COO, H&H Healthcare and Cosmetics

Indore Pharma Summit 2026 | 8th May 2026 | Indore Marriott Hotel The post Mr Ga...

Indore Pharma Summit: Mapping the future of India pharma

From AI and smart manufacturing to sustainability,quality culture,faster drug d...

Parexel to present at eight sessions during DIA Global ...

Company representatives to participate in discussions on AI, clinical trials, ...

Planning for Growth: How Healthcare Systems Are Designi...

Healthcare facilities have always been complex to design and build, but today’s ...

XtalPi enters $400m partnership for small molecule ther...

The collaboration follows a successful pilot phase, where XtalPi’s integrated qu...

CDSCO approves Trastuzumab Deruxtecan for first-line HE...

Approval expands indication for Trastuzumab Deruxtecan in combination with Pert...

Glenmark launches Winlevi for acne vulgaris across Euro...

Launch follows European Commission authorisation and expands availability of c...

ASSOCHAM projects India pharma market at USD 120–130 bi...

Knowledge paper outlines growth drivers, biosimilars opportunity and priorities...

Alembic receives USFDA tentative approval for Larotrect...

Company becomes sole first applicant for generic Larotrectinib Capsules with P...

Axplora consolidates UDCA manufacturing at Vizag site

Company to transition ursodeoxycholic acid production from Italy to India by e...

EMA validates Bayer’s asundexian application for ischae...

EMA has now begun reviewing its use in adults following a non-cardioembolic isch...

Aditxt and Ignite announce merger plans with strategic ...

Upon completion of the transaction, Ignite will separate from Aditxt and is expe...